Skip to content

Canopy News

Featured

Canopy and Rocky Mountain Cancer Centers Announce Multi-Year Partnership to Improve Care with Enterprise AI
Featured

Canopy and Rocky Mountain Cancer Centers Announce Multi-Year Partnership to Improve Care with Enterprise AI

Canopy, the leader in Enterprise AI for oncology, today announced a multi-year partnership with Rocky Mountain Cancer Centers (RMCC), the largest multidisciplinary practice in Colorado dedicated solely to providing care for patients with cancer and diseases of the blood. RMCC will leverage Canopy's Enterprise AI platform across patient services to: Improve operational efficiency and modernize patient communications through AI-enabled workflows, including secure patient messaging and call center support Expand access to novel treatments, such as bispecific and CAR T-cell therapies, and symptom management for all patients through remote therapeutic monitoring Enhance pharmacy workflows and reduce manual processes through automation, including adherence monitoring for oral oncolytics and refill management

Read more

Articles

Canopy and Columbus Oncology & Hematology Announce Partnership to Support Care Between Visits Through Remote Therapeutic Monitoring and Operational AI

Canopy and Columbus Oncology & Hematology Announce Partnership to Support Care Between Visits Through Remote Therapeutic Monitoring and Operational AI

Canopy, the leader in Enterprise AI for oncology, today announced a partnership with Columbus Oncology & Hematology, a leading independent practice in central Ohio and a member of the ONCare Alliance. Columbus Oncology & Hematology is implementing Canopy’s comprehensive platform, including Remote Therapeutic Monitoring (RTM) and operational AI, to support care delivery between visits for both patients and staff.

Read more
Press Release
Clinical

Canopy Studies Selected for Oral and Poster Presentations at 2026 ASCO Annual Meeting

New data demonstrate the potential of the Canopy Remote Therapeutic Monitoring (RTM) Platform to improve patient care by reducing hospitalizations and increasing time on treatment. Canopy, the leader in Enterprise AI for oncology, today announced two abstracts selected for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The studies demonstrate the potential of the Canopy RTM Platform to improve outcomes during systemic outpatient care.

Read more
Canopy Named to the New York Digital Health 100 for Third Consecutive Year
Clinical

Canopy Named to the New York Digital Health 100 for Third Consecutive Year

Canopy, the leader in Enterprise AI for oncology, announced today that it has been named to the 2026 New York Digital Health 100 (DH100) for the third consecutive year, an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Canopy helps cancer centers manage the growing complexity of care by providing an Enterprise AI platform across patient services: triage, call center, front office, referrals, and pharmacy. By embedding AI and automation into existing workflows, Canopy enables faster issue resolution for patients, reduces manual work for staff, and helps practices capture sustainable reimbursement for this care.

Read more

Media Coverage